PROPHYLAXIS OF BLEEDING
Clinical trials for PROPHYLAXIS OF BLEEDING explained in plain language.
Never miss a new study
Get alerted when new PROPHYLAXIS OF BLEEDING trials appear
Sign up with your email to follow new studies for PROPHYLAXIS OF BLEEDING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young hemophilia patients: jivi safety trial shows promise for fewer injections
Disease control CompletedThis study tested the safety of Jivi (BAY 94-9027), a longer-lasting clotting factor, in 36 children aged 7 to 12 with severe hemophilia A. The medicine is already approved for older patients, but this trial focused on younger kids to check for allergic reactions and whether the …
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Personalized dosing for hemophilia a: one step closer?
Disease control CompletedThis study tested a new scoring method to help doctors choose the best dosing schedule of Jivi (a longer-lasting clotting factor) for people with hemophilia A. 21 participants switched from standard treatments to Jivi, and their dose frequency was based on their personal risk sco…
Matched conditions: PROPHYLAXIS OF BLEEDING
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC